No abstract available
MeSH terms
-
Angiogenesis Inhibitors / adverse effects
-
Angiogenesis Inhibitors / economics
-
Angiogenesis Inhibitors / therapeutic use*
-
Antibodies, Monoclonal / adverse effects
-
Antibodies, Monoclonal / economics
-
Antibodies, Monoclonal / therapeutic use*
-
Antibodies, Monoclonal, Humanized
-
Bevacizumab
-
Breast Neoplasms / drug therapy*
-
Breast Neoplasms / mortality
-
Drug Approval*
-
Drug Costs
-
Female
-
Humans
-
Survival Rate
-
United States
-
United States Food and Drug Administration*
Substances
-
Angiogenesis Inhibitors
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Bevacizumab